Column: Coronavirus Pulls Back Curtain on Health Rationing
In a recent guest column published in the Orlando Sentinel, Sue Peschin, president and CEO of the Alliance for Aging [...]
More on Report from Pioneer Institute on QALY
Pharmaphorum in a recent report highlights a new analysis by the Pioneer Institute that suggests the Institute for Clinical and [...]
Analysis Suggests ICER’s QALY Approach Violates ADA
A new analysis by the Pioneer Institute, "The Legality of QALY under the ADA," suggests that the Institute for Clinical [...]
Denmark Adopting QALY System for Hospital Drugs
Denmark is shifting to a new evaluation system for hospital drugs based on the quality-adjusted life year (QALY), according to [...]
New Framework Introduces New Metric in Cost-Effectiveness Analysis
A recent article published in Value in Health proposes a new framework for valuing health outcomes in cost-effectiveness analyses and [...]
Report: Denmark Adopting QALY in Cost-Effectiveness Assessments
Beginning in October, the Danish Medicines Council will use the quality-adjusted life year (QALY) metric in its cost-effectiveness assessments, The [...]
Article: Don’t Let QALY Restrict Life-Saving Drugs
Gunnar Esiason, an MBA/MPH candidate at the Dartmouth Tuck School of Business, in a recent article published on The Hill [...]
